Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leandro Kasuki

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Endocrine Reviews|September 6, 2018
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An UpdateMônica R Gadelha, Leandro Kasuki, Dawn S T Lim, et al.
Endocrine Journal|January 14, 2012
Growth of an aggressive tumor during pregnancy in an acromegalic patientLeandro Kasuki, Leonardo Vieira Neto, Christina M Takiya, et al.
Clinical Endocrinology|March 10, 2018
Treatment escape reduces the effectiveness of cabergoline during long-term treatment of acromegaly in monotherapy or in association with first-generation somatostatin receptor ligandsLeandro Kasuki, Marilia Duarte Dalmolin, Luiz Eduardo Wildemberg, et al.
Endocrine Reviews|July 11, 2025
Medical Treatment of Acromegaly: Navigating the Present, Shaping the FutureMônica R Gadelha, Luiz Eduardo Wildemberg, Nelma Veronica Marques, et al.
Archives of Endocrinology and Metabolism|January 16, 2020
Determinants of morbidities and mortality in acromegalyLeandro Kasuki, Paula da Silva Rocha, Elisa Baranski Lamback, et al.
Journal of Bodywork and Movement Therapies|September 30, 2019
The effectiveness of a therapist-oriented home rehabilitation program for a patient with acromegaly: A case studyTatiana Rafaela Lemos Lima, Leandro Kasuki, Monica Roberto Gadelha, et al.
Pituitary|November 1, 2015
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegalyAnnamaria Colao, Renata S Auriemma, Rosario Pivonello, et al.
Pituitary|May 29, 2023
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findingsPaula Rocha, Julia Barroso, Fernanda Carlos, et al.
Pituitary|February 9, 2025
Headache in pituitary adenomas: frequency, characteristics and outcome after treatmentCristiane R Scaf, Ananda Altoé, Nina Ventura, et al.
International Journal of Molecular Sciences|August 12, 2022
MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor LigandsDaniel G Henriques, Elisa B Lamback, Romulo S Dezonne, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Endocrine Reviews|September 6, 2018
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An UpdateMônica R Gadelha, Leandro Kasuki, Dawn S T Lim, et al.
Endocrine Journal|January 14, 2012
Growth of an aggressive tumor during pregnancy in an acromegalic patientLeandro Kasuki, Leonardo Vieira Neto, Christina M Takiya, et al.
Clinical Endocrinology|March 10, 2018
Treatment escape reduces the effectiveness of cabergoline during long-term treatment of acromegaly in monotherapy or in association with first-generation somatostatin receptor ligandsLeandro Kasuki, Marilia Duarte Dalmolin, Luiz Eduardo Wildemberg, et al.
Endocrine Reviews|July 11, 2025
Medical Treatment of Acromegaly: Navigating the Present, Shaping the FutureMônica R Gadelha, Luiz Eduardo Wildemberg, Nelma Veronica Marques, et al.
Archives of Endocrinology and Metabolism|January 16, 2020
Determinants of morbidities and mortality in acromegalyLeandro Kasuki, Paula da Silva Rocha, Elisa Baranski Lamback, et al.
Journal of Bodywork and Movement Therapies|September 30, 2019
The effectiveness of a therapist-oriented home rehabilitation program for a patient with acromegaly: A case studyTatiana Rafaela Lemos Lima, Leandro Kasuki, Monica Roberto Gadelha, et al.
Pituitary|November 1, 2015
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegalyAnnamaria Colao, Renata S Auriemma, Rosario Pivonello, et al.
Pituitary|May 29, 2023
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findingsPaula Rocha, Julia Barroso, Fernanda Carlos, et al.
Pituitary|February 9, 2025
Headache in pituitary adenomas: frequency, characteristics and outcome after treatmentCristiane R Scaf, Ananda Altoé, Nina Ventura, et al.
International Journal of Molecular Sciences|August 12, 2022
MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor LigandsDaniel G Henriques, Elisa B Lamback, Romulo S Dezonne, et al.
Pageof 9